|Articles|May 21, 2013

Marianne Davies on Evidence- Based Practice at YNHH

Author(s)Marianne Davies, RN, MSN, ACNP, AOCN

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the benefits of the nursing research and evidence-based practice council at Yale-New Haven Hospital.

Davies says that the structure of the council, as it provides protected time to meet, helps to support research at Yale-New Haven Hospital. The institution also provides opportunity for professional and career development as well as patient-centered research initiatives.

Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.

Related to this article

September 24th, 2026

Reframing Nurse Fatigue as Systemic Safety Risk

ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.

September 14th, 2026

Solavia Decision Suite: Key Clinical Insights for APPs and PAs

Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.

September 12th, 2026

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.

September 8th, 2026

FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm

FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.

September 8th, 2026

How the Emerging MPN Pipeline Will Reshape PV Nursing and Patient Care

Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.